Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women

Contraception

Volumn 87, Issue 3, 2013, Pages 352-357

  Edelman, Alison B ^a   Jensen, Jeffrey T ^b   Doom, Carmen ^b   Hennebold, Jon D ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Celecoxib; COX 2 inhibitor; Dysfunctional ovulation; Emergency contraception; Prostaglandin

Indexed keywords

CELECOXIB; LUTEINIZING HORMONE;

ABSENCE OF SIDE EFFECTS; ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; OVULATION; PROGESTERONE SYNTHESIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; CROSS-OVER STUDIES; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUTEAL PHASE; OVULATION; PROSPECTIVE STUDIES; PYRAZOLES; SULFONAMIDES; YOUNG ADULT;

EID: 84873412628     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.07.004     Document Type: Conference Paper

References (25)

1. H.B. Croxatto, V. Brache, and M. Pavez Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation Contraception 70 2004 442 450
2. A.F. Glasier, S.T. Cameron, and P.M. Fine Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Lancet 375 2010 555 562
3. V. Brache, L. Cochon, and C. Jesam Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture Hum Reprod 25 2010 2256 2263
4. D.D. Baird, C.R. Weinberg, D.R. McConnaughey, and A.J. Wilcox Rescue of the corpus luteum in human pregnancy Biol Reprod 68 2003 448 456
5. R.L. Bogan, M.J. Murphy, R.L. Stouffer, and J.D. Hennebold Systematic determination of differential gene expression in the primate corpus luteum during the luteal phase of the menstrual cycle Mol Endocrinol 22 2008 1260 1273
6. B.L. Dennefors, A. Sjogren, and L. Hamberger Progesterone and adenosine 3',5'-monophosphate formation by isolated human corpora lutea of different ages: influences of human chorionic gonadotropin and prostaglandins J Clin Endocrinol Metab 55 1982 102 107
7. M. Hahlin, B. Dennefors, C. Johanson, and L. Hamberger Luteotropic effects of prostaglandin E2 on the human corpus luteum of the menstrual cycle and early pregnancy J Clin Endocrinol Metab 66 1988 909 914
8. G.D. Hodgen, and J. Itskovitz Recognition and maintenance of pregnancy E.N.J. Knobil, The physiology of reproduction 1988 Raven New York 1995 2021
9. E.L. Sargent, W.L. Baughman, M.J. Novy, and R.L. Stouffer Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys Endocrinology 123 1988 2261 2269
10. M.B. Zelinski-Wooten, and R.L. Stouffer Intraluteal infusions of prostaglandins of the E, D, I, and A series prevent PGF2 alpha-induced, but not spontaneous, luteal regression in rhesus monkeys Biol Reprod 43 1990 507 516
11. R. Stouffer Structure, function, and regulation of the corpus luteum J.D. Neill, The physiology of reproduction 2006 Elsevier New York 475 526
12. R.L. Stouffer, W.E. Nixon, and G.D. Hodgen Disparate effects of prostaglandins on basal and gonadotropin-stimulated progesterone production by luteal cells isolated from rhesus monkeys during the menstrual cycle and pregnancy Biol Reprod 20 1979 897 903
13. T. Takahashi, J.D. Morrow, H. Wang, and S.K. Dey Cyclooxygenase-2-derived prostaglandin E(2) directs oocyte maturation by differentially influencing multiple signaling pathways J Biol Chem 281 2006 37117 37129
14. J.E. Dinchuk, B.D. Car, and R.J. Focht Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II Nature 378 1995 406 409
15. R.L. Bogan, M.J. Murphy, R.L. Stouffer, and J.D. Hennebold Prostaglandin synthesis, metabolism, and signaling potential in the rhesus macaque corpus luteum throughout the luteal phase of the menstrual cycle Endocrinology 149 2008 5861 5871
16. J.A. Arosh, S.K. Banu, P. Chapdelaine, E. Madore, J. Sirois, and M.A. Fortier Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function Endocrinology 145 2004 2551 2560
17. M.S. Bata, M. Al-Ramahi, A.S. Salhab, M.N. Gharaibeh, and J. Schwartz Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study J Clin Pharmacol 46 2006 925 932
18. C. Jesam, A.M. Salvatierra, J.L. Schwartz, and H.B. Croxatto Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception Hum Reprod 25 2010 368 373
19. M.R. Massai, M.L. Forcelledo, and V. Brache Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study Hum Reprod 22 2007 434 439
20. K.E. Hester, M.J. Harper, and D.M. Duffy Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception Hum Reprod 25 2010 360 367
21. M. Pall, B.E. Friden, and M. Brannstrom Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study Hum Reprod 16 2001 1323 1328
22. T.W.D. Lemke Table 36.5. Foyle's principles of medicinal chemistry 2008 Lippincott, Williams, Wilkins Baltimore
23. A.B. Edelman, J.T. Jensen, and J.D. Hennebold A nonhormonal model for emergency contraception: prostaglandin synthesis inhibitor effects on luteal function and lifespan, a pilot study Contraception 81 2010 496 500
24. A.D. Rodrigues Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same? Drug Metab Dispos 33 2005 1567 1575
25. D.M. Duffy, and R.L. Stouffer Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys Hum Reprod 17 2002 2825 2831